Vitalean is a personalized weight loss program that uses Semaglutide or Tirzepatide, injectable medications approved by ANVISA and FDA for the treatment of obesity and weight loss.

Mounjaro (tirzepatide) is an injectable medication approved for the treatment of type 2 diabetes in adults and for glycemic control in adults with type 2 diabetes and cardiovascular disease. It can also be used to aid weight loss in adults with an initial body mass index (BMI) of at least 30 kg/m² or an initial BMI of at least 27 kg/m² who also have at least two weight-related comorbidities.

Mounjaro works in two main ways to lower blood sugar and promote weight loss:

1. By activating the GLP-1 and GIP receptors:

Mounjaro is a dual agonist of the GLP-1 (glucagon-like peptide-1) and GIP (intestinal insulinotropic peptide) receptors.

The GLP-1 and GIP receptors are present in several organs, including the pancreas, small intestine, and stomach.

By binding to these receptors, Mounjaro activates them, which leads to several beneficial effects:
Stimulates insulin secretion: Insulin is a hormone that helps transport sugar from the blood into cells, where it can be used for energy. Mounjaro increases insulin secretion, especially when blood sugar levels are high, which helps to reduce blood sugar.
Reduces glucagon production: Glucagon is a hormone that releases glucose (sugar) from the liver into the bloodstream. Mounjaro suppresses glucagon production, which helps to prevent spikes in blood sugar after meals.
Delays gastric emptying: Mounjaro slows the passage of food from the stomach to the small intestine, which promotes feelings of fullness and reduces appetite. This can lead to lower calorie intake and aid in weight loss. Improves insulin sensitivity: Mounjaro makes cells more sensitive to insulin, meaning they need less insulin to absorb sugar from the blood.
2. Activating amylin:

Amylin is a hormone produced by the beta cells of the pancreas.
It works with insulin to regulate blood sugar.
Mounjaro also activates amylin, which amplifies its beneficial effects on blood sugar.
Additional effects:

In addition to lowering blood sugar and promoting weight loss, Mounjaro may also:
Reduce the risk of cardiovascular events in adults with type 2 diabetes and confirmed cardiovascular disease.
Improve blood pressure control.
Reduce LDL (“bad”) cholesterol levels.

Ozempic (Semaglutide) is an injectable medicine used to treat type 2 diabetes and aid weight loss in adults with a body mass index (BMI) over 27 kg/m². It works in three main ways to lower blood sugar and promote weight loss:

1. It stimulates insulin secretion:

Ozempic acts as an analogue of GLP-1 (glucagon-like peptide-1), a natural hormone that regulates blood sugar.

By binding to GLP-1 receptors on beta cells in the pancreas, Ozempic stimulates them to produce more insulin, especially when blood sugar levels are high.

This helps move sugar from the bloodstream into cells, where it can be used for energy.

2. It reduces glucagon production:

Glucagon is another hormone produced by the pancreas that releases glucose (sugar) from the liver into the bloodstream.

Ozempic suppresses the production of glucagon, which helps prevent blood sugar spikes after meals.
3. Delays gastric emptying:

Ozempic slows the passage of food from the stomach to the small intestine, which promotes feelings of fullness and reduces appetite.
This leads to lower calorie intake, which can contribute to weight loss.

Efeitos adicionais:

• Além de baixar o açúcar no sangue e promover a perda de peso, o Ozempic também pode reduzir o risco de eventos cardiovasculares em adultos com diabetes tipo 2 e doenças cardíacas confirmadas.
• No entanto, é importante notar que o Ozempic deve ser usado apenas sob orientação profissional.

The Vitalean program follows a 6-step process:

1. Blood tests: Blood collection to assess your general health and identify possible nutritional deficiencies.
2. Medication evaluation and prescription: Online consultation with a doctor to evaluate test results and prescribe the ideal dose of Semaglutide or Tirzepatide.
3. Bioimpedance assessment: Analysis of body composition to determine muscle mass, fat mass and fluid retention.
4. Exercise and nutrition guidance: Personalized exercise and diet plan to complement medication treatment and promote lasting results. The cost of exercise and nutrition monitoring is not included in the program and must be contracted separately to maximize your weight loss.
5. Monitoring with exams and bioimpedance assessment: Regular monitoring of progress through exams and bioimpedance to adjust treatment as necessary.
6. Weekly injections of medication and vitamins: Weekly application of Semaglutide or Tirzepatide, in addition to vitamins to optimize results, the value of vitamins is not included in the plan and may be indicated by the health professional to complement your weight loss procedure.

• Significant reduction in weight and body fat.
• Improved glycemic control in type 2 diabetics.
• Reduced risk of cardiovascular disease.
• Increased satiety and appetite control.
• Ease of administration: subcutaneous injection once a week.

Vitalean is indicated for adults and young people over 15 years of age who are overweight, obese (BMI greater than 25 kg/m²) who wish to lose weight safely and effectively, or type 2 diabetics.